WEMED Medical Won The Best Enterprise For Innovative Medical Devices in The Excellence List Of HaoYue Capital
On April 3, 2022, Haoyue Capital, a private equity investment fund, specializing in China healthcare, officially released “the 6th Healthcare Investment Excellence List 2022” . WEMED Medical was awarded the "Best Enterprise for Innovative Medical Devices in 2021"
As an annual authoritative list highly recognized by the industry, since its first release in 2017, “the Healthcare Investment Excellence List” has always adhered to the principles of fairness, impartiality, objectivity and neutrality.
The selection of the Excellence List covers five sectors: Biopharma, Medical Devices, IVD and Precision Medicine, Healthcare Services and Digital Health. The list is selected by combining the opinions of authoritative healthcare experts, top investors, professional media, along with return on investment, investment in different sectors and other objective data.
In recent years, WEMED Medical has undertaken the responsibility of the rise of national premium medical brands, forged ahead, pioneered and innovated in order to realize domestic substitution of premium medical equipment. In October 2021, the vascular interventional robot which is independent developed by WEMED Medical has completed the first PCI surgery in Beijing Anzhen Hospital.
WEMED Medical has always adhered to the values “Innovation for Health” . In the future, WEMED Medical will continue to focus on the field of Interventional Medicine. And looking forward to working with HaoYue Capital and other industrial partners.
